Neuroprotective Drug Market to Hit $2.6bn by 2014 Says New Report

According to the 'Neuroprotective Products: World Market Prospects 2012-2022' the neuroprotection market offers strong opportunities for medicines to slow disease progression, protecting the central nervous system (CNS). Our report shows and explains.

The pharma industry will develop more drugs for neuronal protection, with high revenues possible this decade and beyond. The R&D pipeline is strong and promising. Overall world revenues will reach $2.6bn in 2014, our report forecasts.

We predict that the neuroprotection market will achieve strong revenue growth to 2022, especially from 2017. By then, many clinical trials will have finished and products will gain regulatory approval. You see prospects for novel drugs.

Rising incidence and prevalence of neurodegenerative diseases in ageing populations will stimulate that treatment market. Also stimulating the industry and market will be the treatment of brain injuries, especially those from traffic accidents.

This 56 page report discusses Ceregene, Genervon Biopharmaceuticals, Neuren Pharmaceuticals and others, evaluating commercial prospects. The scope of the field is widening, with many organisations entering and collaborating. View the Report: 'Neuroprotective Products: World Market Prospects 2012-2022'

press@reportbuyer.com

44 (0) 20 7060 7474

Pharmaceutical Market Research

Reports analysing global biotechnology, healthcare, medical devices and pharmaceutical companies & markets

Tags: